These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Treatment
32 results:

  • 1. Enhanced glioma cell death with ZnO nanorod flowers and temozolomide combination therapy through autophagy and mitophagy pathways.
    Li Y; Ma Y; Li J; Lu Y; Liu H; Gao M; Cao J
    Biomed Pharmacother; 2024 Sep; 178():117149. PubMed ID: 39047423
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy.
    Atkinson TM; Hay JL; Young Kim S; Schofield E; Postow MA; Momtaz P; Warner AB; Shoushtari AN; Callahan MK; Wolchok JD; Li Y; Chapman PB
    Oncologist; 2023 Apr; 28(4):351-357. PubMed ID: 36745014
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive
    Karaghiannis V; Maric D; Garrec C; Maaziz N; Buffet A; Schmitt L; Antunes V; Airaud F; Aral B; Le Roy A; Corbineau S; Mansour-Hendili L; Lesieur V; Rimbert A; Laporte F; Delamare M; Rab M; Bézieau S; Cassinat B; Galacteros F; Gimenez-Roqueplo AP; Burnichon N; Cario H; Van Wijk R; Bento C; Girodon F; Hoogewijs D; Gardie B
    Haematologica; 2023 Jun; 108(6):1652-1666. PubMed ID: 36700397
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted Therapies in Pheochromocytoma and Paraganglioma.
    Wang K; Crona J; Beuschlein F; Grossman AB; Pacak K; Nölting S
    J Clin Endocrinol Metab; 2022 Nov; 107(11):2963-2972. PubMed ID: 35973976
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Preclinical evaluation of targeted therapies in Sdhb-mutated tumors.
    Moog S; Salgues B; Braik-Djellas Y; Viel T; Balvay D; Autret G; Robidel E; Gimenez-Roqueplo AP; Tavitian B; Lussey-Lepoutre C; Favier J
    Endocr Relat Cancer; 2022 May; 29(6):375-388. PubMed ID: 35348472
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
    Wang K; Schütze I; Gulde S; Bechmann N; Richter S; Helm J; Lauseker M; Maurer J; Reul A; Spoettl G; Klink B; William D; Knösel T; Friemel J; Bihl M; Weber A; Fankhauser M; Schober L; Vetter D; Broglie Däppen M; Ziegler CG; Ullrich M; Pietzsch J; Bornstein SR; Lottspeich C; Kroiss M; Fassnacht M; Wenter VUJ; Ladurner R; Hantel C; Reincke M; Eisenhofer G; Grossman AB; Pacak K; Beuschlein F; Auernhammer CJ; Pellegata NS; Nölting S
    Endocr Relat Cancer; 2022 May; 29(6):285-306. PubMed ID: 35324454
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Belzutifan, a Potent HIF2α Inhibitor, in the Pacak-Zhuang Syndrome.
    Kamihara J; Hamilton KV; Pollard JA; Clinton CM; Madden JA; Lin J; Imamovic A; Wall CB; Wassner AJ; Weil BR; Heeney MM; Vargas SO; Kaelin WG; Janeway KA; Perini RF; Zojwalla NJ; Voss SD; DuBois SG
    N Engl J Med; 2021 Nov; 385(22):2059-2065. PubMed ID: 34818480
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Personalized Management of Pheochromocytoma and Paraganglioma.
    Nölting S; Bechmann N; Taieb D; Beuschlein F; Fassnacht M; Kroiss M; Eisenhofer G; Grossman A; Pacak K
    Endocr Rev; 2022 Mar; 43(2):199-239. PubMed ID: 34147030
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Systematic review and meta-analysis of local recurrence rates of head and neck cutaneous melanomas after wide local excision, Mohs micrographic surgery, or staged excision.
    Bittar PG; Bittar JM; Etzkorn JR; Brewer JD; Aizman L; Shin TM; Sobanko JF; Higgins HW; Giordano CN; Cohen JV; Pride R; Wan MT; Leitenberger JJ; Bar AA; Aasi S; Bordeaux JS; Miller CJ
    J Am Acad Dermatol; 2021 Sep; 85(3):681-692. PubMed ID: 33961921
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pseudohypoxic pheochromocytomas and paragangliomas dominate in children.
    Redlich A; Pamporaki C; Lessel L; Frühwald MC; Vorwerk P; Kuhlen M
    Pediatr Blood Cancer; 2021 Jul; 68(7):e28981. PubMed ID: 33682326
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The VHL/HIF Axis in the Development and treatment of Pheochromocytoma/Paraganglioma.
    Peng S; Zhang J; Tan X; Huang Y; Xu J; Silk N; Zhang D; Liu Q; Jiang J
    Front Endocrinol (Lausanne); 2020; 11():586857. PubMed ID: 33329393
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. METTL3 potentiates resistance to cisplatin through m
    Wei J; Yin Y; Zhou J; Chen H; Peng J; Yang J; Tang Y
    J Cell Mol Med; 2020 Oct; 24(19):11366-11380. PubMed ID: 32857912
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma.
    Persson CU; von Stedingk K; Fredlund E; Bexell D; Påhlman S; Wigerup C; Mohlin S
    Exp Cell Res; 2020 Mar; 388(2):111845. PubMed ID: 31945318
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Postoperative Hearing Preservation in Patients Undergoing Retrosigmoid Craniotomy for Resection of Vestibular Schwannomas: A Systematic Review of 2034 Patients.
    Preet K; Ong V; Sheppard JP; Udawatta M; Duong C; Romiyo P; Nguyen T; Kwan I; Yang I
    Neurosurgery; 2020 Mar; 86(3):332-342. PubMed ID: 31149722
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Collaborative ISL1/GATA3 interaction in controlling neuroblastoma oncogenic pathways overlapping with but distinct from MYCN.
    Zhang Q; Zhang Q; Jiang X; Ye Y; Liao H; Zhu F; Yan J; Luo L; Tian L; Jiang C; Chen Y; Liang X; Sun Y
    Theranostics; 2019; 9(4):986-1000. PubMed ID: 30867811
    [No Abstract]    [Full Text] [Related]  

  • 16. epas1/HIF2α correlates with features of low-risk neuroblastoma and with adrenal chromaffin cell differentiation during sympathoadrenal development.
    Westerlund I; Shi Y; Holmberg J
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1233-1239. PubMed ID: 30563765
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Wnt Signalling Drives Context-Dependent Differentiation or Proliferation in Neuroblastoma.
    Szemes M; Greenhough A; Melegh Z; Malik S; Yuksel A; Catchpoole D; Gallacher K; Kollareddy M; Park JH; Malik K
    Neoplasia; 2018 Apr; 20(4):335-350. PubMed ID: 29505958
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE.
    Mercado-Asis LB; Wolf KI; Jochmanova I; Taïeb D
    Endocr Pract; 2018 Jan; 24(1):78-90. PubMed ID: 29144820
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. HIF-2alpha: Achilles' heel of pseudohypoxic subtype paraganglioma and other related conditions.
    Tella SH; Taïeb D; Pacak K
    Eur J Cancer; 2017 Nov; 86():1-4. PubMed ID: 28946040
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. New HIF2α inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas.
    Toledo RA
    Endocr Relat Cancer; 2017 Sep; 24(9):C9-C19. PubMed ID: 28667082
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.